Stemnovate is soon introducing the microfluidic platform for DNA synthesis. The disruptive technology allows template free DNA/RNA synthesis that can potentially accelerate the development of new therapeutics in the pharmaceutical sector e.g. antibody research, drug bio-production and RNAi based therapeutics. The technology overcomes the current limitations of DNA synthetic technology.


Platform Features
Precision DNA synthesis and high yield with purity harnessing novel enzymatic methodology.

The faster synthesis method surpasses conventional technology for achieving longer product size.

The technology is environmentally friendly with no impact from any harmful reagents.

Rapid template free-Enzymatic DNA Synthesis for short and long oligos.

How it works

Advantages of Stemnovate’s ETFDS
ParametersStemnovate’s enzymatic DNA synthesis platformChemical DNA synthesis and Centralized services
LengthETFDS is capable of generating short to long to ultra-long DNAPhosphoramidite synthetic DNA is limited to < 150mers for a polynucleotide strand.
QualityHigh quality with low impuritiesLevel of impurities increases as DNA length exceeds >150mers
Synthesis MethodUses natural enzymes in aqueous solution.Uses harsh environmentally unfriendly chemicals

The DNA synthesis has potential to revolutionise the field of drug discovery, biotechnology
and nanotechnology.

Drug discovery

The applications are varied such as RNA therapy, antibody research, Vaccine development.


The drug bio-production, biofuel research, crop production and research for food security.


DNA synthesis is being explored for novel DNA data storage and nano-material discoveries.


Our clients say

You are doing some amazing and important work at Stemnovate, we are happy to be associated with your project.

Volunteer for blood donation for liver research

Thank you for your presentations, they were really great and stimulating. I am very happy we met and that we could get the cells in culture!

Academic Institution
University of Bern

CASE STUDIES & Partnership

Partnering for Better Veterinary Research

Stemnovate is partnering up with the world renowned Roslin Institute on a project to create in vitro modelling systems for muscular studies that can help make new discoveries for better animal health and production.

Slippery Liquid-Infused Porous Surfaces: Partnering for Micro-fluidics Smart engineering

Prof Ciro Semprebon will be working in partnership with Stemnovate on the prestigious EPSRC grant project for advancing SLIPS technology.